Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

HMR discloses preparation and use of series with MMP-inhibitory activity

June 26, 1998

Enbrel BLA accepted for review and assigned priority review status

June 25, 1998

Idun discloses new inhibitors of ICE and related proteases

June 24, 1998

Collgard Biopharmaceuticals establishes U.S. subsidiary

June 22, 1998

New agent for rheumatoid arthritis in development by Toray and Kaken

June 19, 1998

MMP-2 and MMP-3 inhibitors identified at Warner-Lambert

June 19, 1998

Angiotech's micellar paclitaxel enters clinic for arthritis

June 18, 1998

Topical antiinflammatory corticosteroid approved for marketing in Japan

June 17, 1998

Santen presents new LTA4 hydrolase inhibitors

June 15, 1998

Preparation and use of new MMP inhibitors from Warner-Lambert

June 12, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
In the clinic for April 21, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Abbott, Agenus, Astrazeneca, Briacell, Clearmind, Greenwich, Intodna,...